The world's first partial heart transplant has achieved what researchers have spent more than a year hoping for—functioning valves and arteries that grow along with the young patient, as hypothesized by the pioneering team ...
Jan 3, 2024
0
94
Across the United States, about 2 million people are living with an amputation and another 185,000 amputations occur every year, according to the Amputee Coalition, a Washington DC-based support group. About 54% of these ...
Dec 19, 2023
0
37
In a new study, researchers at the University of Chicago were able to predict postoperative infections in liver transplant patients by analyzing molecules in their poop. Their analysis represents a key leap forward in exploring ...
Dec 16, 2023
0
53
A new treatment strategy for locally advanced liver cancer, known as "reduce and remove," was announced by the Department of Surgery and Department of Clinical Oncology, Center of Cancer Medicine, School of Clinical Medicine, ...
Dec 14, 2023
0
35
Many Black Americans who are thought to have a high risk of developing kidney disease possess a protective genetic variant that nullifies the extra risk, a new study from Columbia researchers has found. The work is published ...
Dec 11, 2023
0
35
Mortality related to end stage liver disease is ranked as the 12th most common cause of death in the U.S. Liver transplantation remains the only treatment for end stage liver disease, but there is a critical shortage of organ ...
Dec 7, 2023
0
24
3D eye scans can reveal vital clues about kidney health that could help to track the progression of disease, research suggests. The advance could revolutionize the monitoring of kidney disease, which often progresses without ...
Dec 5, 2023
0
83
Mayo Clinic researchers studying the genetics of people who had recently developed dilated cardiomyopathy, one of the most common causes of heart failure, have found a particular gene to target for developing future drug ...
Nov 30, 2023
0
31
When the COVID-19 pandemic first started, no effective anti-viral drugs were available to fight the disease. However, in record time, so-called monoclonal antibodies were developed as a lifesaving treatment. Now, three years ...
Nov 29, 2023
0
65
In a preclinical breakthrough that could transform cell therapies for incurable diseases, researchers at Sinai Health and the University of Toronto have developed a technology that may one day eliminate the need for immunosuppressive ...
Nov 29, 2023
0
38
